新冠XBB的新加坡经验:再感染风险高,毒性低,疫苗及抗体药物无效( 三 )


撰文|文竞择
排版|乔维钧
End
参考资料:
[1]Ngiam,JinghaoNicholasMBBS;Al-Mubaarak,AbdurrahmaanBSc;Maurer-Stroh,SebastianPhD,etal.DoestheCOVID-19XBBOmicronsubvariantsignalthebeginningoftheendofthepandemic?SingaporeMedicalJournal , December01,2022.DOI:10.4103/singaporemedj.SMJ-2022-180.
[2]TomokazuTamura,JumpeiIto,KeiyaUriu,etal.VirologicalcharacteristicsoftheSARS-CoV-2XBBvariantderivedfromrecombinationoftwoOmicronsubvariants.bioRxiv2022.12.27.521986;doi:https://doi.org/10.1101/2022.12.27.521986
[3]UrakiR,ItoM,FurusawaY,etal.HumoralimmuneevasionoftheomicronsubvariantsBQ.1.1andXBB.LancetInfectDis.2023Jan;23(1):30-32.doi:10.1016/S1473-3099(22)00816-7.Epub2022Dec7.PMID:36495917;PMCID:PMC9729000.
[4]WangQ,IketaniS,LiZ,etal.AlarmingantibodyevasionpropertiesofrisingSARS-CoV-2BQandXBBsubvariants.Cell.2022Dec14:S0092-8674(22)01531-8.doi:10.1016/j.cell.2022.12.018.Epubaheadofprint.PMID:36580913;PMCID:PMC9747694.
[5]ImaiM,ItoM,KisoM,etal.EfficacyofAntiviralAgentsagainstOmicronSubvariantsBQ.1.1andXBB.NEnglJMed.2022Dec7:NEJMc2214302.doi:10.1056/NEJMc2214302.Epubaheadofprint.PMID:36476720;PMCID:PMC9749618.
[6]https://covid.cdc.gov/covid-data-tracker/#variant-proportions